April 11, 2022 Atomic Spectroscopy Lab Top-10 Licensing, IP, and Legal Liq. Handling & Robotics

Bruker Announces Key Innovations for Multiplexed Spatial Proteomics and Unbiased Multiomic Imaging for Cancer Research

Bruker launches novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF fleX using AmberGen’s HiPLEX-IHC peptide code antibody probes, combined with unbiased lipidomics, glycomics and metabolomics tissue imaging New Canopy CellScape™ single cell, highly quantitative spatial proteomic ChipCytometry™ platform features fully automated iterative staining using open-source antibodies for virtually unlimited immuno-oncology marker analysis on whole tissue... Read more

April 4, 2022 Lab Top-10 Licensing, IP, and Legal Mass Spectrometry

Bruker Expands dia-PASEF® on the timsTOF 4D Proteomics and Epiproteomics Platform to Identify up to 13,000 Protein Groups with 1% FDR

Innovative TIMScore™ algorithm, combined with TIMS DIA- NN deep learning, now integrated into ‘Run & Done’ Bruker PaSER™2022 proteomics system Identifies and quantifies more than 8000 protein groups (PG) in 35 minute-gradient single dia-PASEF runs from ultra-deep libraries containing over 13,000 PGs in cell-line assays with 1% FDR (false discovery rate) specificity Over 25% more... Read more

March 16, 2022 Lab Top-10 Licensing, IP, and Legal PR/Corporate

Bruker Appoints Philip Ma to its Board of Directors

BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220316005639/en/ Dr. Philip Ma is Chief Executive Officer, President, and Founder of PrognomiQ (Photo: Business... Read more

March 16, 2022 Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

GE Healthcare, AliveCor Partnership Aims to Increase Convenience for Patients and Help Reduce Cardiac-Related Hospitalizations by Improving the Quality and Integration of Patient Data

Physicians accessing GE Healthcare’s MUSE, a cardiac management system that connects to and integrates into the electronic medical record (EMR), can now view and interpret in MUSE ECGs taken by patients using AliveCor’s KardiaMobile 6L personal ECG device, strengthening the care continuum from hospital into the home, or anytime, anywhere. Used by 87 percent of... Read more

March 3, 2022 Lab Top-10 Licensing, IP, and Legal Liq. Handling & Robotics Product Launch

Canopy Biosciences Launches Next-Generation ChipCytometry™ Instrument for Spatial Biology with Sub-Cellular Resolution

New CellScape™ System Provides Exceptional Quantitative Performance for High-Plex and High-Throughput Targeted Spatial Proteomics ST. LOUIS–(BUSINESS WIRE)– Canopy Biosciences, a Bruker Company, today announced the commercial launch of the CellScapeTM system, the next generation in ChipCytometryTM instrumentation, advancing the cutting-edge for quantitative in situ spatial phenotyping. ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue... Read more

February 21, 2022 Licensing, IP, and Legal M&A, Partnerships Product Launch

European Society of Radiology and GE Healthcare renew their strategic partnership for ECR 2022

Vienna, Austria – February 21, 2022 – The European Society of Radiology (ESR) and GE Healthcare announce today the renewal of their partnership for the online European Congress of Radiology (ECR Overture) on March 2-6, 2022, and onsite ECR 2022 on July 13-17 in Vienna, Austria. The partnership includes a complete 2,000m² new area and... Read more

February 7, 2022 Lab Top-10 Licensing, IP, and Legal Liq. Handling & Robotics

Bruker Enables High-Throughput Multiplex HTS on Sierra SPR Platform

Sierra Surface Plasmon Resonance (SPR) Pro Series for High-Throughput Screening (HTS) Innovative Sierra SPR-32 Pro allowing multiplex HTS for insights into kinetics with no compromise in sensitivity and nature of samples SPR insights into molecular interactions by label-free HTS in support of drug discovery BOSTON–(BUSINESS WIRE)– At the SLAS2022 International Conference and Exhibition, Bruker Corporation... Read more